Speakers

David A. Ricks
David A. Ricks
Chair and Chief Executive Officer, Eli Lilly and Company
Lucas Montarce
Lucas Montarce
Executive Vice President and Chief Financial Officer, Eli Lilly and Company
Daniel M. Skovronsky, MD, PhD
Daniel M. Skovronsky, MD, PhD
Chief Scientific and Product Officer, Eli Lilly and Company, and President, Lilly Research Laboratories
Andrew  Adams, PhD
Andrew Adams, PhD
Group Vice President, Molecule Discovery, Eli Lilly and Company
Ilya Yuffa
Ilya Yuffa
Executive Vice President, Eli Lilly and Company, and President, Lilly USA and Global Customer Capabilities

Impact Obesity at Scale

Kenneth L. Custer, PhD
Kenneth L. Custer, PhD
Executive Vice President, Eli Lilly and Company, and President, Lilly Cardiometabolic Health
Ruth Gimeno, PhD
Ruth Gimeno, PhD
Group Vice President, Diabetes and Metabolic Research, Eli Lilly and Company

Big Ideas

Adrienne Brown
Adrienne Brown
Executive Vice President, Eli Lilly and Company, and President, Lilly Immunology
Carole Ho, MD
Carole Ho, MD
Executive Vice President, Eli Lilly and Company, and President, Lilly Neuroscience
Jacob S. Van Naarden
Jacob S. Van Naarden
Executive Vice President, Eli Lilly and Company; President, Lilly Oncology; and Head of Corporate Business Development
Mark C. Genovese, MD
Mark C. Genovese, MD
Senior Vice President, Immunology R&D, Eli Lilly and Company
Mark A. Mintun, MD
Mark A. Mintun, MD
Group Vice President, Neuroscience R&D, Eli Lilly and Company
Kevin Craig, MD
Kevin Craig, MD
Vice President, Late-Phase Neuroscience, Eli Lilly and Company
Kristin Wolff
Kristin Wolff
Associate Vice President, Commercial Gene Therapy and Gene Editing, Eli Lilly and Company
Sekar Kathiresan, MD
Sekar Kathiresan, MD
Senior Vice President, Head of Obesity Research, Eli Lilly and Company
John M. Pagel, MD, PhD
John M. Pagel, MD, PhD
Senior Vice President, Clinical Development; Global Head, Hematology, Eli Lilly and Company
Arjun Balar, MD
Arjun Balar, MD
Senior Vice President, Head of Oncology Global Clinical Development, Eli Lilly and Company
Lillian Smyth, MD
Lillian Smyth, MD
Senior Vice President, Clinical Development; Global Head, Breast Cancer, Eli Lilly and Company